Published in Leukemia on October 01, 1999
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer. Cell Death Differ (2013) 1.60
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood (2005) 1.25
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. Br J Cancer (2002) 0.83
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia. Oncotarget (2015) 0.81
Cytotoxic and apoptotic activities of Amorphophallus campanulatus (Roxb.) Bl. tuber extracts against human colon carcinoma cell line HCT-15. Saudi J Biol Sci (2014) 0.81
Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling. Cell Death Dis (2012) 0.80
Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia. Blood (2016) 0.80
Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis. Am J Pathol (2003) 0.79
An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1. Br J Cancer (2013) 0.79
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia. Haematologica (2013) 0.78
Individualized markers optimize class prediction of microarray data. BMC Bioinformatics (2006) 0.76
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet (1998) 3.91
Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet (1996) 2.84
Recombinant congenic strains--a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics (1986) 2.28
Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology (1999) 2.24
Pulmonary resection for metastases of colorectal origin. Chest (1995) 2.09
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood (1995) 2.00
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol (2003) 1.67
Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci (1982) 1.67
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol (2004) 1.65
The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys (1998) 1.57
Insulin resistance and breast-cancer risk. Int J Cancer (1992) 1.57
Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer (1991) 1.56
Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol (1999) 1.55
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med (1993) 1.55
The interpretation of multiple P-values. Radiother Oncol (1994) 1.54
Lymph node metastasis from melanoma with an unknown primary site. Br J Surg (1990) 1.49
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer (1999) 1.46
Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol (1999) 1.46
Vincristine revisited. Crit Rev Oncol Hematol (1999) 1.46
The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol (1993) 1.42
Detection of systematic patient setup errors by portal film analysis. Radiother Oncol (1992) 1.41
[A cavernous haemangioma of the colon as the cause of rectal bleeding in childhood]. Ned Tijdschr Geneeskd (2004) 1.39
Increased sialic acid density in surface glycoprotein of transformed and malignant cells--a general phenomenon? Cancer Res (1973) 1.36
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia (2007) 1.36
Psychological adaptation and social support of parents of pediatric cancer patients: a prospective longitudinal study. J Pediatr Psychol (2001) 1.28
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood (1997) 1.28
Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia (2001) 1.28
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep (1984) 1.25
Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer (1994) 1.25
Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst (2001) 1.24
Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer (2006) 1.24
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery (1994) 1.23
Does resistance to apoptosis affect clinical response to antitumor drugs? Drug Resist Updat (2001) 1.22
Some prognostic and epidemiologic factors in canine osteosarcoma. J Natl Cancer Inst (1979) 1.21
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. Blood (1999) 1.20
Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia (2005) 1.19
Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol (1993) 1.18
Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1997) 1.18
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants. Leukemia (1998) 1.16
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol (1996) 1.16
Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL. Leukemia (2002) 1.16
Vincristine pharmacokinetics after repetitive dosing in children. Cancer Chemother Pharmacol (1999) 1.14
Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J Pediatr (2001) 1.14
Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun (2000) 1.12
The development of a prognostic score for patients with parotid carcinoma. Cancer (1999) 1.11
Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J Natl Cancer Inst (1990) 1.11
Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications. Heart (1998) 1.10
Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry (1987) 1.10
Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer (1988) 1.08
Discrepancies between precursor uptake and DNA synthesis in mammalian cells. J Cell Physiol (1969) 1.08
The H-reflex of the flexor carpi radialis muscle; a study in controls and radiation-induced brachial plexus lesions. J Neurol Neurosurg Psychiatry (1984) 1.08
Repairable and irrepairable damage in 5-bromouracil-substituted DNA exposed to ultra-violet radiation. Int J Radiat Biol Relat Stud Phys Chem Med (1971) 1.08
Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol (1984) 1.07
Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes. Cancer (2000) 1.07
A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res (1998) 1.07
Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart (1998) 1.07
Stage as major long term outcome predictor in minor salivary gland carcinoma. Cancer (2000) 1.07
Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer (1995) 1.06
Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood (1986) 1.06
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol (1999) 1.05
Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology (1983) 1.05
Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol (1983) 1.04
Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. Oncogene (1992) 1.04
The effect of chemotherapy on the growing skeleton. Cancer Treat Rev (2000) 1.03
Carbohydrates of the tumor cell surface. Biochim Biophys Acta (1984) 1.03
Microenvironmental studies of pre-B and B cell development in human and mouse fetuses. J Immunol (1982) 1.03
BCL-2 expression and mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid-induced apoptosis. Blood (1994) 1.02
Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver. Eur J Cancer (2003) 1.02
Quality of life in bone tumor patients comparing limb salvage and amputation of the lower extremity. J Surg Oncol (1992) 1.02
The prevalence of mental health problems in Rwandan and Burundese refugee camps. Acta Psychiatr Scand (2000) 1.02
Ras (proto)oncogene induces N-linked carbohydrate modification: temporal relationship with induction of invasive potential. EMBO J (1988) 1.02
Hemopoiesis in human fetal and embryonic liver. Microsc Res Tech (1997) 1.02
Magnetic resonance imaging of the brain and neuropsychological evaluation in children treated for acute lymphoblastic leukemia at a young age. Am J Pediatr Hematol Oncol (1993) 1.01
Non-Hodgkin's lymphomata: clinical features in relation to histology. Br J Cancer Suppl (1975) 1.01
The presence of cytokines in Langerhans' cell histiocytosis. J Pathol (1996) 1.01
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol (1989) 1.01
Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Hum Reprod (2010) 1.00
Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma. Gynecol Oncol (1997) 0.99
Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. Med Pediatr Oncol (2000) 0.98
Risk factors for psychological maladjustment of parents of children with cancer. J Am Acad Child Adolesc Psychiatry (1999) 0.98
Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases. Clin Chim Acta (1985) 0.97
Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc Natl Acad Sci U S A (1996) 0.97
Acute lymphoblastic leukemia and obesity: increased energy intake or decreased physical activity? Support Care Cancer (2008) 0.97
Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer (1992) 0.97
Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species? Int J Oncol (2002) 0.96
Brief report: an intervention program for parents of pediatric cancer patients: a randomized controlled trial. J Pediatr Psychol (1998) 0.96
Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach. Radiother Oncol (1988) 0.96
Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy. Radiother Oncol (1994) 0.95
pH in human tumor xenografts and transplanted rat tumors: effect of insulin, inorganic phosphate, and m-iodobenzylguanidine. Cancer Res (1992) 0.95
Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Crit Rev Oncol Hematol (1997) 0.95
Health-related quality of life and adverse late effects in adult (very) long-term childhood cancer survivors. Eur J Cancer (2006) 0.95
Spread according to histology in non-Hodgkin's lymphomata. Br J Cancer Suppl (1975) 0.95
Prognostic factors in canine mammary cancer. J Natl Cancer Inst (1976) 0.95
Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor. Br J Haematol (2001) 0.95
Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease. Br J Haematol (2000) 0.95